Market Overview

2 Day Conference: Next-Gen Regenerative Medicine & Tissue Engineering -


The "Next-Gen
Regenerative Medicine & Tissue Engineering Conference"

conference has been added to's

Ethical and regulatory parameters lay a special emphasis on animal
modeling to carry forward the researches over tissue engineering and
organ transplantation. This is one of the major challenge being faced
for the clinical applications of regenerative medicine.

The translational research promises to improvise a structural shift in
healthcare by focusing on the underlying causes of disease by repairing,
replacing, or regenerating damaged cells in the body. The conference
aims on these similar lines to assess risks and benefits of regenerative
medicine through the application of cellular therapies, stem cells and
biocompatible materials.

The event provider has put together a platform for the leading experts
of industry to discuss strategies, technologies and innovations in
tissue engineering & biomaterials, cellular therapies and diagnosis of
regenerative medicines at the Next-Gen Regenerative Medicine & Tissue
Engineering Conference.

Key Highlights

  • Cell based tissue engineering
  • Tissue-specific biomarkers
  • Tissue scaffolding
  • Cell surface profiling
  • Processing of iPSC cells
  • iPSC derived mesenchymal cells
  • T-cell identification and regulation
  • Regulatory and ethical issues of regenerative medicines
  • Genetic models for neurodegenerative disorders
  • Organ transplantation and regeneration


Advisory Committee:

Francisco Vidal Fayos
Director, Aastrom Biosciences

Dr. Tiffany Rau
Senior Consultant, Bioprocessing Technology

Alain Vertes
Managing Director, NxR Biotechnlogies GMBH

Expert Speakers:

Alain Vertes
Managing Director, NxR Biotechnlogies GMBH, Switzerland

Wilfred T.V. Germeraad
Chief Scientific Officer, CiMaas BV,

Philippe Henon
President & Chief Scientific Officer, CellProthera,

Roland Klar
Head of Regenerative Medicine, Ludwig Maximilian
University of Munich, Germany

Yang (Ted) D. Teng
Ph.D., M.D., Departments of Physical Medicine &
Rehabilitation (PM&R) & Neurosurgery, Harvard Medical School, Boston,

Suwan N. Jayasinghe
Professor, Bioengineering, University College
London, UK

James Adjaye
Chair of Stem Cell Research & Regenerative Medicine,
Director, Institute for Stem Cell Research & Regenerative Medicine,

Alexander Seflian
Director & Professor of Nanotechnology &
Regenerative Medicine, The London BioScience Innovation Center,UK

Antonio Apicella
Researcher, University of Campania, Italy

Roland Hetzer
Cardiac Surgeon, Germany

Oliver Betz
Director, Regenerative Medicine, Ludwig-Maximilians
-University, of Munich, Germany

Tiffany Rau
Senior Consultant, Bioprocessing Technology
Consultants, USA

David Gilham
Vice President, Research & Development, Celyad, Belgium

For more information about this conference visit

View Comments and Join the Discussion!